Search hospitals > California > Fremont
Palo Alto Medical Foundation-Fremont
Claim this profileFremont, California 94538
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
78 reported clinical trials
9 medical researchers
Summary
Palo Alto Medical Foundation-Fremont is a medical facility located in Fremont, California. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Breast cancer and other specialties. Palo Alto Medical Foundation-Fremont is involved with conducting 78 clinical trials across 245 conditions. There are 9 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Kristie A. Bobolis.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus8 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Lung Cancer
30 reported clinical trials
68 drugs studied
Christopher JonesSutter Medical Center Sacramento4 years of reported clinical research
Studies Parotid Gland Cancer
Studies Brain Tumor
26 reported clinical trials
69 drugs studied
Deepti BehlCalifornia Pacific Medical Center-Pacific Campus5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
50 drugs studied
Kristie A. BobolisSutter Medical Center Sacramento1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
9 reported clinical trials
24 drugs studied
Clinical Trials running at Palo Alto Medical Foundation-Fremont
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast cancer
Ovarian Cancer
Parotid Gland Cancer
Skin Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Esophageal cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Palo Alto Medical Foundation-Fremont?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.